Liraglutide – Description

Liraglutide is a prescription medication belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class. It is used mainly for the management of type 2 diabetes mellitus and chronic weight management in certain patients with obesity or overweight associated with medical conditions. It is administered as a once-daily subcutaneous injection. Brand names include Victoza and Saxenda.

Liraglutide works by mimicking the natural GLP-1 hormone, which helps regulate blood sugar levels by:

• Stimulating insulin release when blood glucose levels are elevated
• Reducing glucagon secretion from the pancreas
• Slowing stomach emptying
• Increasing feelings of fullness and reducing appetite

Medical Uses

Liraglutide is approved for:

• Improving blood glucose control in adults and children aged 10 years and older with type 2 diabetes
• Reducing the risk of major cardiovascular events such as heart attack and stroke in adults with type 2 diabetes and cardiovascular disease
• Supporting long-term weight management when combined with a reduced-calorie diet and exercise

Clinical Benefits

Studies have shown that liraglutide may:

• Help lower HbA1c and improve glycemic control
• Promote weight reduction
• Improve satiety and reduce calorie intake
• Lower cardiovascular risk in some patients with type 2 diabetes

Common Side Effects

The most frequently reported side effects include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal discomfort
• Injection-site reactions

These gastrointestinal symptoms are usually more noticeable at the beginning of treatment and may decrease over time.

Important Warnings

Liraglutide should be used cautiously in patients with:

• History of pancreatitis
• Severe gastrointestinal disease
• Kidney impairment
• Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Patient Disclaimer

This information is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Patients should use liraglutide only under the supervision of a qualified healthcare provider. Do not start, stop, or change the dosage of any medication without consulting your physician or pharmacist. Seek immediate medical attention if severe side effects or allergic reactions occur.